Blood and bone marrow transplantation for acute myeloid leukemia

Luis M. Villela, Javier Bolaños-Meade

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Bone marrow transplantation is the treatment of choice for some patients with acute myeloid leukemia and myelodysplastic syndrome (MDS). Patients with high-risk disease, such as those with MDS, in second (or subsequent) complete remission or those with poor-risk cytogenetics will benefit the most from this approach. With current transplantation techniques, outcomes have improved over recent years. Although relapse and graft-versus-host disease still are important problems faced by these patients, novel approaches have been developed to decrease the risk of complications, with excellent results.

Original languageEnglish (US)
Pages (from-to)E11-E21
JournalClinical Leukemia
Issue number2
StatePublished - 2009


  • Donor lymphocyte infusion
  • Graft-versus-host disease
  • Myelodysplastic syndrome
  • Promyelocytic leukemia

ASJC Scopus subject areas

  • Oncology
  • Hematology


Dive into the research topics of 'Blood and bone marrow transplantation for acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this